Bivalirudin in Patients with Coronary Artery Disease

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 8, Iss. 4, 2010-10 ,pp. : 199-203

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical utility of β-blockers for primary and secondary prevention of coronary artery disease

By Calhoun McKenzie   Cross L Brian   Cooper-DeHoff Rhonda M  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 3, 2013-03 ,pp. : 289-291

Informa Healthcare

Access to resources Recommend Favorite

Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update

By  

Current Cardiology Reviews, Vol. 9, Iss. 4, 2013-11 ,pp. : 331-339

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting

By Koster A.   Spiess B.   Chew D.P.   Krabatsch T.   Tambeur L.   DeAnda A.   Hetzer R.   Kuppe H.   Smedira N.G.   Lincoff A.M.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 356-359

Elsevier

Access to resources Recommend Favorite

Coronary artery disease management with ivabradine in clinical practice

By Pinto Fausto J.  

European Heart Journal Supplements, Vol. 13, Iss. 1, 2011-09 ,pp. : 25-29

Oxford University Press

Access to resources Recommend Favorite